• Martha T Manda-Mapalo, Stephanie G Fine, Sarah Safadi, Ji-Hyun Lee, Ruofei Du, Andrew L Sussman, Shiraz Mishra, Reed G Selwyn, Jennifer L Saline, Wendy L Hine, and Ursa A Brown-Glaberman.
• Division of Hematology/Oncology, MSC 07-4025, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, USA.
• J Womens Health (Larchmt). 2020 Dec 1; 29 (12): 1596-1601.

AbstractIntroduction: Digital breast tomosynthesis (DBT) may decrease recall rates (RRs) and improve positive predictive values (PPVs) and cancer detection rates (CDRs) versus full-field digital mammography (FFDM). The value of DBT has not been assessed in New Mexico's rural and minority population. Objectives of this study were to compare RRs, CDRs, and PPVs using FFDM+DBT versus FFDM in screening mammograms at the University of New Mexico between 2013 and 2016 and to qualitatively evaluate patient decision-making regarding DBT. Materials and Methods: RRs, CDRs, and PPVs with 95% confidence intervals and relative risk were calculated from 35,147 mammograms. The association between relative risk and mammography approach was tested using Pearson's chi-square test. Twenty women undergoing screening were interviewed for qualitative evaluation of decision-making. Results: From 2013 to 2016, RRs were 8.4% and 11.1% for FFDM+DBT and FFDM, respectively. The difference in RRs became more pronounced with time. No significant difference was observed in PPVs or CDRs. Qualitative interviews revealed that the majority had limited prior knowledge of DBT and relied on provider recommendations. Conclusion: In New Mexico women undergoing screening mammography, a 30% relative risk reduction in RRs was observed with FFDM+DBT. Qualitative interviews suggest that women are aware of and receptive to DBT, assuming adequate educational support. Clinical Trials.gov ID: NCT03979729.

22 keywords...

hide…